{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:05:23Z","timestamp":1775592323386,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eplepsyres.2025.107671","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:17:53Z","timestamp":1760138273000},"page":"107671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epilepsy in children and adolescents with B-cell acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-8706","authenticated-orcid":false,"given":"Sun Ah","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daanish","family":"Unwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6230-223X","authenticated-orcid":false,"given":"Shifteh","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107671_bib1","article-title":"Characterizing the phenotype of drug-resistant childhood epilepsy associated with leukemia: a case series","volume":"15","author":"Abushanab","year":"2021","journal-title":"Epilepsy Behav. Rep."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpn.2020.04.004","article-title":"Seizures during treatment of childhood acute lymphoblastic leukemia: a population-based cohort study","volume":"27","author":"Anastasopoulou","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib3","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3324\/haematol.2021.280016","article-title":"Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes","volume":"107","author":"Anastasopoulou","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0887-8994(02)00508-8","article-title":"Seizures in children with systemic cancer","volume":"28","author":"Antunes","year":"2003","journal-title":"Pedia Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69263-0","article-title":"Potential neurotoxicity associated with methotrexate","volume":"14","author":"Apiraksattayakul","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","article-title":"Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia","volume":"32","author":"Bhojwani","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.seizure.2008.10.008","article-title":"Intractable epilepsy in patients treated for childhood acute lymphocytic leukemia","volume":"18","author":"Fasano","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1684\/epd.2016.0879","article-title":"Drug-resistant epilepsy after treatment for childhood acute lymphocytic leukaemia: from focal epilepsy to Lennox-Gastaut syndrome","volume":"18","author":"Gonz\u00e1lez-Ot\u00e1rula","year":"2016","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1528-1157.2003.20302.x","article-title":"Mesial temporal sclerosis in acute childhood leukemias","volume":"44","author":"Goyal","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/08830738030180060701","article-title":"Atonic seizures in survivors of childhood cancer","volume":"18","author":"Khan","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib12","article-title":"Clinical analysis of childhood acute lymphoblastic leukemia with epilepsy seizures","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.2020.268565","article-title":"Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia","volume":"107","author":"Mateos","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1528-1157.1995.tb01622.x","article-title":"Prognosis and treatment of seizures in children with acute lymphoblastic leukemia","volume":"36","author":"Maytal","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.leukres.2017.12.010","article-title":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","volume":"65","author":"Millan","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib16","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/leu.2014.142","article-title":"A revised definition for cure of childhood acute lymphoblastic leukemia","volume":"28","author":"Pui","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.eplepsyres.2025.107671_bib17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/epd2.20280","article-title":"Developmental and epileptic encephalopathies after successful treatment of pediatric ALL: a case series and review of literature","volume":"26","author":"Shukla","year":"2024","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2025.107671_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105515","article-title":"Neurotoxicity associated with treatment of acute lymphoblastic leukemia chemotherapy and immunotherapy","volume":"23","author":"\u015aliwa-Tytko","year":"2022","journal-title":"Int J. Mol. Sci."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012112500172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012112500172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T20:43:40Z","timestamp":1764017020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092012112500172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":18,"alternative-id":["S092012112500172X"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107671","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy in children and adolescents with B-cell acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107671"}}